The disclosure provides a molecular genetic approach of targeted mutagenesis and heterologous expression, coupled with in vitro and in vivo models of bacterial pathogenesis, to demonstrate that the
S. aureus
pigment is a virulence factor and potential novel target for antimicrobial therapy.
ANTIMICROBIAL COMPOSITIONS FOR TREATING MICROBIAL INFECTIONS
申请人:NIZET Victor
公开号:US20140154302A1
公开(公告)日:2014-06-05
The disclosure provides compounds and methods to treat a microbial or a bacterial pathogenesis, and demonstrates that the
S. aureus
pigment is a virulence factor and potential novel target for antimicrobial therapy.